ofloxacin has been researched along with Myopia in 5 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Myopia: A refractive error in which rays of light entering the EYE parallel to the optic axis are brought to a focus in front of the RETINA when accommodation (ACCOMMODATION, OCULAR) is relaxed. This results from an overly curved CORNEA or from the eyeball being too long from front to back. It is also called nearsightedness.
Excerpt | Relevance | Reference |
---|---|---|
"The ciprofloxacin eyes were significantly more prone to impaired or delayed wound healing and to the development of corneal haze." | 2.69 | Epithelial healing rates with topical ciprofloxacin, ofloxacin, and ofloxacin with artificial tears after photorefractive keratectomy. ( Chuang, AZ; Kiang, E; Mitra, S; Patel, GM; Ramesh, N; Yee, RW, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gris, O | 1 |
Güell, JL | 1 |
Wolley-Dod, C | 1 |
Adán, A | 1 |
Lang, J | 1 |
Rah, MJ | 1 |
Patel, GM | 1 |
Chuang, AZ | 1 |
Kiang, E | 1 |
Ramesh, N | 1 |
Mitra, S | 1 |
Yee, RW | 1 |
Hutchinson, K | 1 |
Apel, A | 1 |
Yu, EY | 1 |
Rao, SK | 1 |
Cheng, AC | 1 |
Law, RW | 1 |
Leung, AT | 1 |
Lam, DS | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Randomized Clinical Trial Comparing the Effect of Moxifloxacin Versus Gatifloxacin Following Pterygium Excision on Corneal Epithelial Healing and Epithelial Toxicity.[NCT00892918] | 40 participants (Anticipated) | Interventional | 2009-06-30 | Not yet recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for ofloxacin and Myopia
Article | Year |
---|---|
Epithelial healing rates with topical ciprofloxacin, ofloxacin, and ofloxacin with artificial tears after photorefractive keratectomy.
Topics: Administration, Topical; Adult; Anti-Infective Agents; Ciprofloxacin; Corneal Topography; Drug Thera | 2000 |
4 other studies available for ofloxacin and Myopia
Article | Year |
---|---|
Diffuse lamellar keratitis and corneal edema associated with viral keratoconjunctivitis 2 years after laser in situ keratomileusis.
Topics: Adenovirus Infections, Human; Anti-Infective Agents; Astigmatism; Conjunctivitis, Viral; Corneal Ede | 2004 |
Adverse corneal events associated with corneal reshaping: a case series.
Topics: Adult; Anti-Bacterial Agents; Child; Contact Lenses; Corneal Ulcer; Eye Infections, Bacterial; Femal | 2004 |
Infectious keratitis in orthokeratology.
Topics: Acanthamoeba Keratitis; Adult; Antiprotozoal Agents; Astigmatism; Benzamidines; Chloramphenicol; Con | 2002 |
Bilateral peripheral corneal infiltrates after simultaneous myopic laser in situ keratomileusis.
Topics: Administration, Topical; Adult; Anti-Infective Agents; Anti-Inflammatory Agents; Corneal Diseases; C | 2002 |